Half of children in with treatable mental health disorders in the United States do not get treatment; a small study demonstrated benefit with immunotherapy for glioblastoma; a task force recommends counseling services for new mothers at risk of depression.
Of the 7.7 million children in the United States with a treatable mental health disorder, half do not receive the necessary treatment, according to a study published in JAMA Pediatrics. The study also found that there was significant variation by state, with Alabama, Mississippi, Oklahoma, and Utah having the highest rates of untreated children.A small study demonstrated that giving patients with glioblastoma immunotherapy before surgery helped them live longer than patients who started drugs after the surgery, STAT. While most patients died by the end of the study, the researchers said the results suggest that timing may be an important factor in treating the disease with the class of drugs.As a result of a recommendation from the US Preventive Services Task Force (USPSTF) on Tuesday, women who are pregnant or have just given birth will get coverage for counseling services if they are risk of depression. According to The Wall Street Journal, USPSTF recommended that women receive counseling if they have any risk factors, including a history of depression or anxiety or complications during pregnancy.
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Trastuzumab Deruxtecan Receives FDA Approval for HER2-Positive Solid Tumors
April 5th 2024FDA granted accelerated approval to trastuzumab deruxtecan-nxki for adult patients with unresectable or metastatic HER2-positive solid tumors who received prior systemic treatment and have no satisfactory alternative treatment options.
Read More